Table 4.
Characteristics of patients developing incident eGFR<60 mL/min/1.73 m2
| Incident eGFR<60 mL/min/1.73 m2 |
|||
|---|---|---|---|
| Yes (n=153) | No (n=486) | p Value | |
| Age (years) | 73.2±8.2 | 68.7±8.8 | <0.001 |
| Body mass index (kg/m2) | 27.5±4.5 | 28.2±4.7 | 0.090 |
| Women (%) | 45.1 | 34.4 | 0.016 |
| Permanent AF (%) | 39.2 | 41.2 | 0.760 |
| Ankle-Brachial Index ≤0.90 (%) | 23.5 | 14.4 | 0.008 |
| Arterial hypertension (%) | 90.8 | 83.7 | 0.030 |
| Diabetes (%) | 18.3 | 24.1 | 0.137 |
| Heart failure (%) | 12.4 | 17.7 | 0.124 |
| History of stroke/TIA (%) | 11.1 | 11.1 | 1.000 |
| History of MI/CHD (%) | 17.0 | 16.7 | 0.925 |
| Antiplatelet (%) | 16.3 | 21.8 | 0.087 |
| ACE inhibitors/ARBs (%) | 72.5 | 71.0 | 0.759 |
| β blockers (%) | 49.0 | 46.5 | 0.586 |
| Calcium channel antagonists (%) | 28.1 | 25.3 | 0.492 |
| Statins (%) | 44.4 | 43.0 | 0.754 |
ACE, angiotensin converting enzyme; AF, atrial fibrillation; ARBs, angiotensin receptor blockers; CHD, coronary heart disease; eGFR, estimated glomerular filtration rate; MI, myocardial infarction; TIA, transient ischaemic attack.